Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders

Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders

US Patent 8580807 · Granted Nov 12, 2013

Estimated economic value: $66,896,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bax inhibitors and uses thereof2025
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabo2025
Aldoketo reductase inhibitors and uses thereof2025
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2025
Inhibitors of GLI1 as therapeutic agents2025
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2024
Aldoketo reductase inhibitors and uses thereof2024
Pharmaceutical compounds for treatment of medical disorders2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2024
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, re2024
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2023
Amino compounds for treatment of immune and inflammatory disorders2023